Industry
153d agoEli Lilly Invests $2.75B in Insilico
The $2.75 billion partnership between Eli Lilly and Insilico Medicine marks a pivotal shift toward AI‑driven drug discovery.
The Signal
By leveraging machine‑learning models to predict molecular properties, the deal could accelerate the development of new therapies worldwide, reduce costs, and set a precedent for cross‑industry collaboration in life‑sciences innovation and foster global health equity.